https://www.selleckchem.com/products/ots514.html
ebral Haemorrhage trials studies are registered with ClinicalTrials.gov (NCT00226096 and NCT00716079). The aim of this study was to determine the risk of recurrent intracerebral haemorrhage (ICH), ischaemic stroke, all stroke, any vascular event and all-cause mortality in 30-day survivors of ICH, according to age and sex. We linked national hospital discharge, population and cause of death registers to obtain a cohort of Dutch 30-day survivors of ICH from 1998 to 2010. We calculated cumulative incidences of recurrent ICH, ischaemic strok
Beğen
Yorum Yap
Paylaş
